Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal cancer, ovarian can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• APG-2449

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Advanced Solid Cancer, Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING